Drug Trial Radar · NCT05669001
A Study of TCD601 in de Novo Renal Transplant Recipients
Last checked: Nov 20, 2026Latest source record: May 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
76
Actual
Start
Dec 28, 2023
Primary completion
Apr 10, 2026
Study completion Apr 10, 2026
Sponsor
- Lead sponsor
- ITB-Med LLCIndustry
- Sponsor type
- Industry
- First posted
- Dec 30, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety and efficacy of TCD601 in combination with Belatacept when compared to standard of care immunosuppression therapy in de novo renal transplant patients.
Conditions
- Renal Transplantation
Interventions
TCD601Biological
Investigational Product
belataceptBiological
Study Product
ATGDrug
Comparator
TACDrug
Comparator
MPADrug
Immunosuppression Therapy
CorticosteroidsDrug
Immunosuppression Therapy
Primary outcomes
What the sponsor says the trial is designed to measure.
- The incidence of adverse events (AEs) and serious adverse events (SAEs) in Arm 1 compared to Arm 2Time frame: 12 months
Locations
18 sites in 1 country. Site status is shown where the registry gives one.
University of California Davis Medical Center
Sacramento, California
University of California San Francisco Medical Center
San Francisco, California
Tampa General Hospital
Tampa, Florida
Emory University Hospital
Atlanta, Georgia
Northwestern University
Chicago, Illinois
Loyola University Medical Center
Maywood, Illinois
Ochsner Clinic Foundation
New Orleans, Louisiana
Massachusetts General Hospital
Boston, Massachusetts
Henry Ford Hospital
Detroit, Michigan
Mayo Clinic
Rochester, Minnesota
University of Nebraska Medical Center
Omaha, Nebraska
Atrium Health Wake Forest Baptist Medical Center
Winston-Salem, North Carolina
University of Cincinnati Medical Center
Cincinnati, Ohio
University of Pennsylvania
Philadelphia, Pennsylvania
Medical University of South Carolina
Charleston, South Carolina
Houston Methodist Hospital
Houston, Texas
University of Virginia Health
Charlottesville, Virginia
Inova Fairfax Hospital Medical Campus
Falls Church, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.